BIOMAT Database Logo BIOMAT Database Logo

Intraventricular and parenteral gentamicin therapy for ventriculitis in children. 1978

L K Pickering, and C D Ericsson, and G Ruiz-Palacios, and J Blevins, and M E Miner

Five children with intraventricular shunts developed ventriculitis due to organisms resistant to multiple antimicrobial agents but sensitive to gentamicin sulfate. No gentamicin was detected in ventricular CSF of four patients at a time when gentamicin was being administered only intravenously. The intraventricular administration of 1 mg of gentamicin resulted in ventricular CSF concentrations greater than 20 microgram/ml one hour and 5 to 14 microgram/ml 36 hours after administration. Patients were treated with intraventricularly given gentamicin for an average of 16 days, with no apparent complications or relapses during the 12- to 24-month follow-up period. Intraventricularly administered gentamicin sulfate (1 mg every 24 to 36 hours) in conjunction with complete shunt removal was an effective means of therapy of ventriculitis caused by bacteria resistant to antibiotics that readily penetrate the blood-brain barrier.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D007276 Injections, Intraventricular Injections into the cerebral ventricles. Intraventricular Injections,Injection, Intraventricular,Intraventricular Injection
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D002552 Cerebral Ventricles Four CSF-filled (see CEREBROSPINAL FLUID) cavities within the cerebral hemispheres (LATERAL VENTRICLES), in the midline (THIRD VENTRICLE) and within the PONS and MEDULLA OBLONGATA (FOURTH VENTRICLE). Foramen of Monro,Cerebral Ventricular System,Cerebral Ventricle,Cerebral Ventricular Systems,Monro Foramen,System, Cerebral Ventricular,Systems, Cerebral Ventricular,Ventricle, Cerebral,Ventricles, Cerebral,Ventricular System, Cerebral,Ventricular Systems, Cerebral
D002557 Cerebrospinal Fluid Shunts Tubes inserted to create communication between a cerebral ventricle and the internal jugular vein. Their emplacement permits draining of cerebrospinal fluid for relief of hydrocephalus or other condition leading to fluid accumulation in the ventricles. Cerebrospinal Fluid Shunt,Shunt, Cerebrospinal Fluid,Shunts, Cerebrospinal Fluid
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial

Related Publications

L K Pickering, and C D Ericsson, and G Ruiz-Palacios, and J Blevins, and M E Miner
Successful treatment of ventriculitis by continuous intraventricular irrigation with gentamicin solution.
March 1974, Surgical neurology,
L K Pickering, and C D Ericsson, and G Ruiz-Palacios, and J Blevins, and M E Miner
Intrathecal gentamicin in treatment of ventriculitis in children.
May 1967, British medical journal,
L K Pickering, and C D Ericsson, and G Ruiz-Palacios, and J Blevins, and M E Miner
[Neonatal meningitis, ventriculitis, intraventricular therapy or not?].
August 1985, Tijdschrift voor kindergeneeskunde,
L K Pickering, and C D Ericsson, and G Ruiz-Palacios, and J Blevins, and M E Miner
Successful treatment of pseudomonas aeruginosa--ventriculitis with intraventricular gentamicin in a child with hydrocephalus.
January 1977, Scandinavian journal of infectious diseases,
L K Pickering, and C D Ericsson, and G Ruiz-Palacios, and J Blevins, and M E Miner
Intraventricular cephalothin in childhood ventriculitis.
September 1975, Surgical neurology,
L K Pickering, and C D Ericsson, and G Ruiz-Palacios, and J Blevins, and M E Miner
Neurosurgical gram-negative bacillary ventriculitis and meningitis: a retrospective study evaluating the efficacy of intraventricular gentamicin therapy in 31 consecutive cases.
June 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
L K Pickering, and C D Ericsson, and G Ruiz-Palacios, and J Blevins, and M E Miner
Increased endotoxin and interleukin-1 beta concentrations in cerebrospinal fluid of infants with coliform meningitis and ventriculitis associated with intraventricular gentamicin therapy.
November 1989, The Journal of infectious diseases,
L K Pickering, and C D Ericsson, and G Ruiz-Palacios, and J Blevins, and M E Miner
Intraventricular gentamicin.
October 1980, Lancet (London, England),
L K Pickering, and C D Ericsson, and G Ruiz-Palacios, and J Blevins, and M E Miner
Intraventricular vancomycin for treatment of shunt-associated ventriculitis.
February 1987, The Journal of antimicrobial chemotherapy,
L K Pickering, and C D Ericsson, and G Ruiz-Palacios, and J Blevins, and M E Miner
Intraventricular vancomycin for treatment of shunt-associated ventriculitis.
August 1987, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!